SmartHealth Dx Experienced Leadership with Proven Success in Development and Commercialization

Mitch Levine
Chief Executive Officer & Chairman of the Board
I joined SmartHealth Dx in November 2022 as our Chief Executive Officer. With my rich strategic-minded background as a corporate finance innovator and investment industry leader, I have orchestrated mission-critical financial strategies to enhance corporate value and strengthen operating performance for public and private companies in the life sciences industry. Read More
From 2017 to 2022, I led Oncocyte as their Chief Financial Officer of Oncocyte, a molecular diagnostic company, where I oversaw corporate growth from eight to more than 120 employees; conducted ten capital raises, bringing the company to fully-funded status; built the shareholder base from one institutional investor to more than fifty; negotiated and integrated three acquisitions; and secured the most significant licensing deal in company history with one of the largest and fastest-growing diagnostic laboratories in China. From 2000 to 2017, Mr. Levine was Founder and Managing Member of Enable Capital Management, LLC, whose underlying investment vehicle, Enable Growth Partners, LP, was one of the largest funds providing growth capital to small and mid-sized public and private companies. Before Enable Capital Management, Mr. Levine was a Founding Member of The Shemano Group, a San Francisco-based investment bank focused on the capital needs of technology and life science companies where Mr. Levine was widely recognized for originating and developing one of the largest alternative financing markets in the US, generating more than $100 billion of financings annually.

Matthew Nuñez
President & Chief Business Officer, Director
I currently hold the positions of President, Chief Business Officer, and Director here at SmartHealth Diagnostics.
A technology executive with over 25 years of business experience bringing new products and concepts to commercial markets. I have expertise in biomarker discovery and development and have been published as an innovator in a scientific journal. Additionally, I was co-founder of Liquid Biosciences, which is focused on advanced AI and bioinformatics. I am highly proficient in mechanical engineering. Read More
Built a commercial partnership with the University of Pennsylvania’s School of Translational Medicine and have developed among the world’s first multi-omic biomarker discovery laboratories. This work was published in scientific journals and is widely recognized for its innovations. I have made novel discoveries in oncology, autoimmune disease, drug response companion diagnostics, and kidney and liver disease. This work has led to our current development partnership with Mayo Clinic. A named inventor in several technologies and was granted US Patents in areas of Drug response to the TNF Class of drugs, the second largest in the world.I have served on Public and Private company Boards, in numerous C-suite roles, and as a Founder.

Lance White
Chief Financial Officer
I started with SmartHealth Dx as the Chief Financial Officer in June of this year. I began my career as an analyst on Wall Street. I obtained a master’s in accounting, became a CPA, and spent several years in public accounting at KPMG, conducting audits on public companies and providing transaction advisory services.
I then went to work at Goldman Sachs, where I was a controller in the Merchant Banking Division, overseeing finance and accounting operations for several of the firm’s private equity and debt funds. Read More
Over the last few years, I went in-house with VC firms and their underlying portfolio companies. I joined the team here to establish an effective accounting and financial reporting framework, formulate and execute business strategy, and implement scalable operational procedures to prepare the company for SmartHealth’s anticipated rapid growth.

Susie Lu
Chief Operating Officer
I bring years of experience to my role as Chief Operating Officer. I have manage large-scale, highly complex diagnostic and ambulatory operations for Columbia HCA Hospitals, UCSF, Stanford, and UCLA Health System. In addition, I consulted on healthcare system operations for the University of Colorado Health System, Adventist Hospitals in California and Florida, as well as major healthcare systems in Vietnam and China. Read More
I am best known for my innovative vision and strategic operational skills to implement entrepreneurial business operations in all of the health systems I have managed. The pathology and laboratory outreach program I implemented at Stanford grew from $0 to $300 M in three years. After seeing SmartPath’s disruptive technology, I joined SmartHealth Dx to oversee the clinical and technical operations of pathology and laboratory products.

Larry Dentice
Chief Commercial Officer & Director
I currently hold the position of CCO and Director of SmartHealth Dx, overseeing the commercialization and distribution of the diagnostic and imaging platforms.
As a Senior healthcare executive and a 40-year veteran of the diagnostics imaging field with proven expertise, I have experience in engineering, service, manufacturing, marketing, sales, and business operations for several Fortune 500 companies including: Read More
I also held key industry position board seats on both the Radiological Society of North America (RSNA) and Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA).

Paul Dentice
President Imaging Technologies
In March 2022, I joined SmartHealth Dx as President of Imaging, overseeing all aspects of the SmartPath Dx instrument. I am a results-driven healthcare professional with 23 years in Diagnostic Imaging, Sales, Technical, and Leadership roles with industry leaders at Philips, Siemens, and GE Healthcare.
I began my career in sales with Philips Healthcare, quickly showing year-over-year growth resulting in promotions into ascending leadership roles, ultimately responsible for leading regions and 200 salespeople at Philips and Siemens, and lastly, running the CT and Vascular business nationally at GE and managing $300M in sales annually. Read More
I have established key partnerships with market leaders and academics such as USC, Cedars-Sinai, UCLA, Common Spirt, Providence, and Kaiser. My longstanding history of developing and motivating top-performing teams to exceed revenue and market share objectives has earned me some top honors, which include: 2019-21 GE Presidents Club Winner, 17-19 Siemens Apex Crest Award Winner, 2016 Siemens Leadership Rookie of the Year, and 7x Philips Pinnacle Award Recipient. I have maintained an impressive track record for developing key relationships with market leaders and academics, exceeding quotas, and growing market share with my team.